Mariner Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-83,700
Closed -$5.35M 146
2016
Q1
$5.35M Buy
83,700
+19,100
+30% +$1.2M 1.47% 20
2015
Q4
$4.44M Sell
64,600
-10,000
-13% -$661K 0.99% 31
2015
Q3
$4.42M Buy
74,600
+30,000
+67% +$1.9M 0.89% 36
2015
Q2
$2.97M Buy
+44,600
New +$2.94M 0.76% 47

Other funds holding BMY

Mariner Investment Group's BMY Position: Q2 2016 in Review

Mariner Investment Group sold out of Bristol-Myers Squibb (BMY) in Q2 2016, closing a stake of 83,700 shares — an estimated $5.35M sold.

Mariner Investment Group first reported a position in BMY in Q2 2015 and held it in 4 quarters. The position peaked at $5.35M in Q1 2016. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

  • Mariner Investment Group reported no remaining Bristol-Myers Squibb position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 83,700 Bristol-Myers Squibb shares in Q2 2016, an estimated $5.35M.
  • Mariner Investment Group first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 4 quarters.
  • Mariner Investment Group's Bristol-Myers Squibb position peaked at $5.35M in Q1 2016.
  • 1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.